Clinical Trial Update: Lantus in Prediabetes [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Lantus (insulin glargine) in individuals with Prediabetes/Hyperglycemia/Diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hyperglycemia
• Prediabetes

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Hyperglycemia, Diabetes Mellitus | Phase 1 | Status: COMPLETED